Results 71 to 80 of about 9,260 (254)
Indipendenza delle banche centrali in dodici paesi industrializzati
Moneta e Credito, 2013 There has recently been worldwide interest in the question of greater monetary policy autonomy for central banks. According to the December 1991 Treaty on European Economic and Monetary Union (EMU), for example, the European Central Bank is supposed to ...
S. EIJFFINGER, E. SCHALING
doaj +1 more source
A sustainable business ecosystem: a case study demonstrating biochar's potential
Biofuels, Bioproducts and Biorefining, EarlyView.Abstract The need for renewable, climate‐friendly resources has become urgent as legislators worldwide have sought to find ways to cut emissions while ensuring resource security for consumers. The use of biochar could help to achieve these goals. This study examines the current state of commercial biochar production and the maturity of the related ...
Juuso Kivijakola +4 more
wiley +1 more source
Central bank independence in twelve industrial countries
PSL Quarterly Review, 2013 There has recently been worldwide interest in the question of greater monetary policy autonomy for central banks. According to the December 1991 Treaty on European Economic and Monetary Union (EMU), for example, the European Central Bank is supposed to ...
S. EIJFFINGER, E. SCHALING
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
The EMU is Done. How about the Fiscal Union and the Next Future of the United Europe? [PDF]
Theoretical and Applied Economics, 2009 The economic and monetary union was actually compulsory, despite that the Maastricht Treaty does not express as such. Moreover, specialists argue that the monetary union is equally required to be fiscal as well. And what is this? Of course, strenghtening
Liviu C. Andrei
doaj +1 more source
Nominal and Real Convergence as a Determinant for Joining the European Monetary Union
ECONOMICS, 2017 The thematic framework of this work is the nominal and real convergence as a determinant for joining the European monetary union. The focus of the work is to prove that realising the criteria of the convergence affects the stability of the European ...
Kasumović Merim, Heric Erna
doaj +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
British Journal of Clinical Pharmacology, EarlyView.Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
Coordination of Monetary and Fiscal Policy in the European Monetary Union
Management, 2014 Given the presence of numerous fiscal policy holders and only one central bank within the European Monetary Union, the coordination of macroeconomic policies has two dimensions – the coordination among fiscal policy holders and the coordination among ...
Damir Šehović
doaj +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
British Journal of Clinical Pharmacology, EarlyView.The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source